Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2013 February;65(1) > Minerva Ginecologica 2013 February;65(1):89-97





A Journal on Obstetrics and Gynecology

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index




Minerva Ginecologica 2013 February;65(1):89-97

language: Italian

Evaluation of the myo-inositol-monacolin k association on hyperandrogenism and on the lipidic metabolism parameters in pcos women

Musacchio M. C., Cappelli V., Di Sabatino A., Morgante G., De Leo V.

Clinica Ostetrica e Ginecologica, Università Degli Studi di Siena, Siena, Italia


Aim: Polycystic ovary syndrome (PCOS) is a multifactorial pathology affecting 5-10% of the female population. Usually occurs with oligo/amenorrhea, anovulation, hirsutism, polycystic ovaries. Hyperinsulinemia associated with insulin resistance has been causally linked to all features of the syndrome. It has been demonstrated that by reducing hyperinsulinemia, in particular with the administration of metformin, insulin-lowering agents might improve endocrine and reproductive abnormalities in PCOS patients.
Methods: A new molecule with insulin-sensitizing properties, myo-inositol, has recently been successfully administered in women with PCOS. New associations between natural substances like myo-inositol and other components have been proposed to improve the therapeutical efficacy. Among these substances, the monacolin K, a natural statin appeared to have important actions in cholesterol synthesis. In this article we study the effect of inositol alone and the association between myo-inositol and monacolinin K in the treatment of PCOS with insulin resistance, menstrual irregularities and hirsutism.
Results and conclusion: The results of this study demonstrated a good efficacy of both treatments, although in the group treated with the combination of myo-inositol/monacolin K improvement in lipids and hyperandrogenismwere significantly better.

top of page

Publication History

Cite this article as

Corresponding author e-mail